Andrew Rosell is a member of Winstead's Corporate, Securities/Mergers & Acquisitions Practice Group. Andrew has a diverse corporate and securities practice representing private investment fund managers, wealth managers, mutual fund managers, family offices and public and private companies engaged in strategic transactions. Andrew primarily focuses on representing registered investment advisers in all aspects of their business, including: formation and structuring, regulatory compliance, strategic transactions (e.g. seed deals and growth acceleration transactions), strategic mergers and acquisitions, investment portfolio transactions, due diligence, fund formation and liquidation and business cessation.

Andrew also has significant industry experience beyond investment management.  He regularly represents and works with companies in the oil & gas, insurance and healthcare industries. In this capacity, he often acts as outside general counsel addressing corporate governance, employment and contract negotiations, as well as negotiating merger and acquisition transactions.

Andrew is a member of the board of trustees for Cook Children’s Medical Foundation where he serves on the Audit Committee, and the boards of directors for Cook Children’s Medical System and Cook Children’s Health Plan.

Andrew is the former General Counsel and Chief Compliance Officer at Kleinheinz Capital Partners, Inc., a multi-billion dollar SEC registered investment adviser. During his tenure at Kleinheinz Capital Partners, Inc., he managed the compliance program and legal functions. Prior to attending law school, Andrew was a staff auditor with Ernst & Young LLP, focusing on real estate audit and consulting.

Andrew is the co-author of Winstead’s Investment Insights Blog.